“a significant trend”

For cheese intake, a significant trend was identified at 6 months ( p = 0.007), and cheese intake ≥ 7 servings/week showed a reduced prevalence of insufficient sleep (adjusted OR = 0.001, 99.2% CI: 0.000–0.168).

Specifically, lower albumin levels were associated with an increased likelihood of being in the Moderate Progression group (missing data exclusion: OR = 0.95, 95% CI: 0.91–0.99, p = 0.025; 10-year follow-up: OR = 0.95, 95% CI: 0.91–0.99, p = 0.016) and a significant trend towards decreased likelihood in the Rapid Progression group (missing data exclusion: OR = 0.87, 95% CI: 0.78–0.96, p = 0.007; 10-year follow-up: OR = 0.9, 95% CI: 0.82–0.98, p = 0.022) compared to the Slow Progression group.

However, a significant trend was observed for certain cosmetic ingredients, such as pentylene glycol ( p = 0.007), retinol ( p = 0.052), and glycolic acid ( p = 0.062) (Table SIII ).

Results In rats, analyzed MRI scans showed a significant trend of increase in the % gadolinium in brain tissues as a result of hyperbaric oxygen pressures ( p-value = 0.0079 ).

When the prevalence of asthma was estimated only among patients with COVID-19 ( Table 2 ), a significant trend was observed, both in children and adults, with decreases in the asthma prevalence rates in waves II (odds ratio [OR], 0.74; P = .008; OR, 0.73; P < .001, respectively), III (OR, 0.62; P < .001; OR, 0.58; P < .001, respectively), IV (OR, 0.68; P < .001; OR, 0.70; P < .001, respectively) and V (OR, 0.53; P < .001; OR, 0.62; P < .001, respectively) compared with those in wave I ( Table 2 ).

When analyzed categorically, participants in the highest MLR tertile (T3) maintained a significantly elevated odds of PAD even in the fully adjusted model (Model 5: OR = 2.25, p = 0.008), with a significant trend across tertiles ( p = 0.008).

A multiple comparison following a significant trend of CPK levels in the intervention and control group 1, with a corrected level of significance based on the Bonferroni correction (P<0.008), was applied.

In the higher quartiles of blood cadmium, there were significantly higher proportions of females, those with high school or equivalent education, those with lower household incomes, current smokers, and stroke patients. Blood cadmium concentration and stroke As shown in Table 2 , in the most adjusted model, participants in quartiles 2, 3, and 4 had an OR for stroke compared with the lowest reference group for blood cadmium in the total population, with OR of 1.32 (95% CI 0.55–3.14), 1.65 (95% CI 0.71–3.83), and 2.67 (95% CI 1.10–6.49), respectively, with a significant trend (p = 0.008).

The Cochran–Armitage trend test revealed a significant trend of a higher prevalence of VA in the order of STTH, N-STTH, and NMNT headache ( P = 0.008) ( Fig. 2 ).

Those who were extremely religious were significantly less likely to be vaccinated (aOR = 0.5; 95% CI: 0.3–0.9) compared to individuals who were not at all religious, and there was a significant trend of decreasing likelihood of COVID-19 receipt with increasing religiosity ( p = 0.008).

A significant trend indicated a lower OS as the N status increased (for N0: 42 [95% CI 34–50) months; N1: 32 [95% CI 28–36] months; N2: 24 [95% CI 14–35] months; p = 0.008).

Finally, the comparison of the latent classes across the attitudinal and demographic variables, via the Chi-squared and the Jonckheere–Terpstra (JT) tests, revealed that a significant trend exists for the belief that healthcare institutions should provide mediation training (trainbyinstit, JT p = 0.008), with recorded scores increasing significantly across profiles from cautiously positive to moderately supportive to strongly supportive.

Figure 1 and Figure 2 depicted a significant trend association between the case numbers and the seasonal and monthly temperatures ( p = 0.008 and p = 0.005). 3.5.

Similarly, a significant trend towards better outcomes was observed with increasing Kawaguchi scores ( p = 0.009), with grade 1 tumors having a 51.7% lower probability of good outcomes compared to grade 3 ( Figure 4 and Figure 5 ).

The subgroup analysis by analgesic type in our meta-analysis revealed a significant trend toward reduced PCA use with ESPB compared to morphine (MD: -8.78, 95%CI: -15.34 to -2.22, P = 0.009).

When analyzed by quartiles, a significant trend emerged (OR: 0.85 per quartile increase, 95% CI: 0.75-0.96, P=0.009).

In addition, meta-regression of serum gastrin elevation ( Figure 4(e) and ( f )) revealed a significant positive correlation with both treatment duration and vonoprazan dosage, where longer therapy was associated with greater gastrin elevation compared with lansoprazole (coefficient = 1.7972 per week, p < 0.0001) and higher vonoprazan doses showed a significant trend toward increased gastrin levels (coefficient = 9.3422 per mg, p = 0.0093).

If a significant trend was detected at p ≤ 0.01, Williams’ test was used [ 21 ]; if the trend was not significant Dunnett’s test was used [ 22 ].

Plasma NGAL levels also increased progressively with AKI stage: 481.6 ng/mL (stage 1), 625.5 ng/mL (stage 2), and 760.2 ng/mL (stage 3), showing a significant trend ( P < 0.01).

There was a significant trend (Armitage trend test p < 0.01) of decreasing IFI incidence with increasing GA, falling from 4.6% at 22–23 weeks GA to 0.2% at 28 weeks GA ( Figure 3 ).

Conversely, in the population of patients with sperm abnormality, we found a significant trend increase from day 1 to day 7 of TSC (16.38 vs. 56.0; p<0.01), sperm concentration (million/ml) (8.0 vs. 18.0; p<0.01) and morphology (3.0 vs. 5.0; p<0.01).

If a significant trend was detected at p ≤ 0.01, Williams’ test was used ( Williams, 1986 ); if the trend was not significant, Dunnett’s test was used ( Dunnett, 1955 ).

However, a significant trend of higher LN count and higher likelihood of liver metastases was observed ( P = 0.010).

Similarly, the Social Vulnerability Index showed a significant trend for the percentage of those without a high school diploma (β = 0.02, p<0.01).

Compared with the latter, our cohort presented increased mutation frequency of DUSP2 , BTG2 , IRF4 , MEF2B , MYC , CD79B , BCL7A , NFKBIE , FAS , and CIITA ( p < 0.05), with a significant trend toward changes in TP53 , CCND3 , CD58 , and CXCR4 ( p < 0.01).